Research shows benefit of dapagliflozin for heart failure pa

Dapagliflozin reduces the risks of death and cardiovascular events in patients with heart failure regardless of ejection fraction, according to late-breaking research presented in a Hot Line session today at ESC Congress 2022.

Related Keywords

United Kingdom , Pardeep Jhund , Emily Henderson , Professor University Of Glasgow , Hot Line , Study Author , Professor University , Heart , Heart Failure , Ardiology , Hospital , Placebo , Research ,